Search Results - "BLONSKI, J. Z"

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine by Robak, T., Blonski, J.Z., Gora-Tybor, J., Kasznicki, M., Konopka, L., Ceglarek, B., Komarnicki, M., Lewandowski, K., Hellmann, A., Lewandowski, K., Moskwa, A., Dmoszyńska, A., Sokołowska, B., Dwilewicz-Trojaczek, A., Tomaszewska, A., Sułek, K., Całbecka, M.

“…The increased frequency of second malignancies in chronic lymphocytic leukaemia (CLL) is well known. Moreover, antineoplastic therapy additionally increases…”
Get full text

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia by ROBAK, T, BŁONSKI, J. Z, D.WOŁOWIEC, STELLA-HOŁOWIECKA, B, SKOTNICKI, A. B, NOWAK, W, MOSKWA-SROKA, B, DMOSZYNSKA, A, CALBECKA, M, KASZNICKI, M, GORA-TYBOR, J, DWILEWICZ-TROJACZEK, J, BOGURADZKI, P, KONOPKA, L, CEGLAREK, B, SUŁEK, J, KULICZKOWSKI, K

“…The objective of the study was to determine the effectiveness and the toxicity of a combined chemotherapy consisting of cladribine (2-CdA), mitoxantrone and…”
Get full text

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial) by Chanan-Khan, A, Egyed, M, Robak, T, Martinelli de Oliveira, F A, Echeveste, M A, Dolan, S, Desjardins, P, Blonski, J Z, Mei, J, Golany, N, Zhang, J, Gribben, J G

Get full text

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias by Wojcik, I, Szybka, M, Golanska, E, Rieske, P, Blonski, J Z, Robak, T, Bartkowiak, J

“…Abnormalities of the P53 network have been implicated in the pathogenesis of acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML). The…”
Get more information

Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine by Robak, T, Kasznicki, M, Bloński, J Z, Dmoszyńska, A, Skotnicki, A B

Get full text

Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia by Gora-Tybor, J, Blonski, J Z, Robak, T

“…We investigated the serum concentration of basic fibroblast growth factor (bFGF) and transforming growth factor beta1 (TGFbeta1), using an enzyme linked…”
Get full text

The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast by Jeziorski, A, Blonski, J Z, Niewiadomska, H

“…The aim of the study was to examine the consecutive series of primary ductal invasive tumours and find out: a) the expression of some biological cellular…”
Get more information

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients by ROBAK, T, BLONSKI, J. Z, TOMASZEWSKA, A, HELLMANN, A, LEWANDOWSKI, K, KULICZKOWSKI, K, POTOCZEK, S, ZDZIARSKA, B, HANSZ, J, KROLL, R, KOMARNICKI, M, HOŁOWIECKI, J, KASZNICKI, M, GRIEB, P, KONOPKA, L, CEGLAREK, B, DMOSZYNSK, A, SOROKA-WOJTASZKO, M, SKOTNICKI, A. B, NOWAK, W, DWILEWICZ-TROJACZEK, J

“…Between January 1992 and January 1999, we treated 378 B‐chronic lymphocytic leukaemia (CLL) patients with cladribine (2‐CdA), and 255 of the patients were also…”
Get full text

2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells by Gora-Tybor, J, Lech-Miranda, E, Blonski, J Z, Robak, T

Get more information

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2‐CdA): an unusual variant of Richter's syndrome by Robak, T., Urbańska‐Ryś, H., Strzelecka, B., Krykowski, E., Bartkowiak, J., Boński, J. Z., Kordek, R., Warzocha, K.

“…: Patients with chronic lymphocytic leukemia (CLL) may develop a large‐cell transformation known as Richter's syndrome (RS). RS usually presents as diffuse…”
Get full text

A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients by Niewiadomska, H, Mirowski, M, Stempien, M, Olborski, B, Blonski, J Z, Hanausek, M, Wierzbicki, R

“…Paraffin-embedded tissue slides from 89 infiltrating ductal breast carcinoma, 10 fibrocystic disease and 10 fibroadenoma were assessed immunohistochemically…”
Get full text

Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignancies by Robak, T, Szmigielska-Kapłon, A, Błoński, J Z, Kasznicki, M, Chojnowski, K

“…We determined the effectiveness and toxicity of combined chemotherapy consisting of etoposide 100 mg/m(2)/day i.v. and cladribine (2-CdA) 0.12 mg/kg/day i.v…”
Get more information

P632: ORAL AND GUT MICROBIAL DIVERSITY CORRELATES WITH PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA by Szelest, M., Paziewska, M., Kiełbus, M., Masternak, M., Zaleska, J., Wawrzyniak, E., Kalicińska, E., Jabłonowska, P., Wróbel, T., Wolska‐Washer, A., Błoński, J. Z., Giannopoulos, K.

Get full text

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger by ROBAK, T, BŁONSKI, J. Z, URBANSKA-RYS, H, BŁASINSKA-MORAWIEC, M, SKOTNICKI, A. B

“…The aim of the study was to determine the effectiveness of 2-chlorodeoxyadenosine (2-CdA) administered in 2-h i.v. infusions in the treatment of B cell chronic…”
Get full text

Expression of an oncofetal 65-kDa phosphoprotein in lymphocytic and granulocytic leukemias by Hanausek, M, Wang, S C, Blonski, J Z, Kulesza, E P, Walaszek, Z, Mirowski, M

“…We examined the expression of an oncofetal 65-kDa phosphoprotein, termed p65, in patients with lymphocytic and granulocytic leukemia. This protein was…”
Get more information

Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission by Robak, T, Wierzbowska, A, Błasińska-Morawiec, M, Korycka, A, Błoński, J Z

“…WE have investigated the serum concentrations of interleukin-6 (IL-6) and two IL-6 family cytokines-oncostatin M (OSM) and leukemia inhibitory factor (LIF)-in…”
Get full text

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia by Robak, T, Błasińska-Morawiec, M, Błoński, J.Z, Krykowski, E, Komarnicki, M, Trepińska, E, Kaźmierczuk, M, Hansz, J, Dmoszyńska, A, Roliński, J, Konopka, L, Skotnicki, A.B, Nowak, W.S, Kotlarek-Haus, S, Zdziarska, B, Urasiński, I

“…2-Chlorodeoxyadenosine (2-CdA) is a new antimetabolite chemotherapeutic agent active in indolent lymphoid malignancies. In this retrospective study, 69…”
Get full text

Richter's Syndrome Following Cladribine Therapy for Chronic Lymphocytic Leukemia First Manifested as Pathologic Fracture of the Femur by Robak, Tadeusz, Kasznicki, Marek, Bartkowiak, Jacek, Kordek, Radzislaw, Wawrzyniak, Ewa, Blonski, Jerzy Z.

“…Richter's syndrome (RS) refers to the development of aggressive non-Hodgkin's lymphoma (NHL) during the course of chronic lymphocytic leukaemia (CCL). It…”
Get full text

Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias by Balcerczak, E, Bartkowiak, J, Błoński, J Z, Robak, T, Mirowski, M

“…In this study we have established conditions for p65 gene expression analysis by reverse transcriptase polymerase chain reaction (RT-PCR). On the basis of this…”
Get full text

Does Intensive Treatment with High Dose Chlorambucil and Prednisone as First Line and Cladribine as Second Line Influence the Survival of the Patients with Chronic Lymphocytic Leukemia? by Robak, Tadeusz, B onski, Jerzy Z., Kasznicki, Marek

“…Cladribine (2-CdA) and fludarabine are the new purine analogs introduced in the treatment of chronic lymphocytic leukemia (CLL). Despite the high response…”
Get full text